Related Experiment Video
Updated: Feb 8, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
MiRNA-26a promotes angiogenesis in a rat model of cerebral infarction via PI3K/AKT and MAPK/ERK pathway
1Department of Neurosurgery, Lianjiang Hospital Affiliated To Guangdong Medical University/Lianjiang People's Hospital, Lianjiang, China. liangzaizai008@163.com.
Objective:
To investigate the specific role of microRNA-26 (miRNA-26a) in a rat model of cerebral ischemic stroke and the underlying mechanism.
Materials And Methods:
A rat model of middle cerebral artery occlusion (MCAO) was established to induce permanent cerebral infarction. Neuro-behavior was observed and scored after model establishment. The expression of miRNA-26a in brain tissue and brain microvascular endothelial cells (BMECs) of rats after cerebral ischemic stroke was detected by quantitative polymerase chain reaction (qPCR). The formation of the endothelial lumen was detected by Matrigel assay after BMECs were transfected with miR-26a mimics or inhibitors. Besides, cell proliferation after miRNA-26a transfection was detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. The protein levels related to PI3K/AKT and MAPK/ERK signaling pathway were detected by Western blot.
Results:
miRNA-26a expression was elevated after cerebral infarction injury. Further investigation showed that miRNA-26a mimics could promote endothelial lumen formation and cell proliferation in BMECs, while miRNA-26a inhibitor inhibited the capacity of lumen formation and cell proliferation. Notably, we found that miRNA-26a might up-regulate the expression of HIF-1a via activating the AKT and ERK1/2 pathway, thus mediating the transcriptional activity of VEGF and promoting lumen formation and cell proliferation in BMECs.
Conclusions:
MiRNA-26a promotes angiogenesis in a rat model of cerebral ischemic via PI3K/AKT and MAPK/ERK pathway.
Insights
MicroRNA-26a promotes blood vessel formation in rats after ischemic stroke. It activates signaling pathways to enhance cell growth and repair, aiding recovery from brain injury.
Area of Science:
- Neuroscience
- Molecular Biology
- Cardiovascular Research
Background:
- Cerebral ischemic stroke remains a leading cause of disability.
- Understanding the molecular mechanisms of angiogenesis is crucial for developing effective treatments.
- MicroRNAs play significant roles in regulating cellular processes relevant to stroke recovery.
Purpose of the Study:
- To investigate the specific role of microRNA-26a (miRNA-26a) in a rat model of cerebral ischemic stroke.
- To elucidate the underlying molecular mechanisms by which miRNA-26a influences angiogenesis and cell proliferation.
Main Methods:
- Established a rat model of middle cerebral artery occlusion (MCAO) to induce cerebral infarction.
- Quantified miRNA-26a expression using qPCR in brain tissue and brain microvascular endothelial cells (BMECs).
- Assessed endothelial lumen formation, cell proliferation (MTT assay), and signaling pathway activation (Western blot for PI3K/AKT and MAPK/ERK).
Main Results:
- miRNA-26a expression was significantly elevated following cerebral infarction.
- miRNA-26a mimics promoted endothelial lumen formation and BMEC proliferation, while inhibitors reduced these effects.
- miRNA-26a was found to up-regulate HIF-1a via the AKT and ERK1/2 pathways, subsequently promoting VEGF transcription.
Conclusions:
- miRNA-26a plays a critical role in promoting angiogenesis post-cerebral ischemic stroke.
- The pro-angiogenic effects of miRNA-26a are mediated through the PI3K/AKT and MAPK/ERK signaling pathways.
- Targeting miRNA-26a may represent a therapeutic strategy for enhancing recovery after ischemic stroke.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results...
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Models of Health Promotion and Illness Prevention I
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...

